117-10-2
基本信息
1,8-二羥基喹酮
1,8-二羥基-9,10-蒽二酮
丹蒽醌
1,8-蒽醌二酚
以斯替凈
1,8-二羥基蒽醌/丹蒽醌
1,8-二羥蒽醌
金黃異茜素
1, 9-DIHYDROXYANTHRAQUINONE
ALTAN
ANTHRAPUROL
CHRYSAZIN
CHRYSAZINE
DANTHRON
DANTRON
ISTIZIN
ISTIZINE
LABOTEST-BB LT00455159
1,4,5,8-tetroxyantraquinone
1,8-dihydroxy-10-anthracenedione
1,8-Dihydroxy-9,10-anthracenedione
1,8-Dihydroxy-9,10-anthraquinone
1,8-Dihydroxyanthra-9,10-quinone
1,8-Dihydroxyanthrachinon
1,8-dihydroxy-anthraquinon
1,8-dihydroxyanthroquinone
9,10-Anthracenedione, 1,8-dihydroxy-
物理化學(xué)性質(zhì)
安全數(shù)據(jù)
知名試劑公司產(chǎn)品信息
Chrysazin,>98.0%(T)(117-10-2)
報(bào)價(jià)日期 | 產(chǎn)品編號(hào) | 產(chǎn)品名稱(chēng) | CAS號(hào) | 包裝 | 價(jià)格 |
2024/11/08 | A12001 | 1,8-二羥基蒽醌, 95%
1,8-Dihydroxyanthraquinone, 95% | 117-10-2 | 100g | 601元 |
2024/11/08 | A12001 | 1,8-二羥基蒽醌, 95%
1,8-Dihydroxyanthraquinone, 95% | 117-10-2 | 500g | 1478元 |
2024/11/08 | 11483 | 1,8-二羥基蒽醌(95%) 1,8-Dihydroxyanthraquinone, 95%, Thermo Scientific Chemicals | 117-10-2 | 5g | 420元 |
常見(jiàn)問(wèn)題列表
AMPK
|
Danthron (0.1, 1, and 10 μM) dose-dependently promotes the phosphorylation of AMPK and acetyl-CoA carboxylase (ACC) in both HepG2 and C2C12 cells. Meanwhile, Danthron treatment significantly reduces the lipid synthesis related sterol regulatory element-binding protein 1c (SREBP1c) and fatty acid synthetase (FAS) gene expressions, and the total cholesterol (TC) and triglyceride (TG) levels. In addition, Danthron treatment efficiently increases glucose consumption. Danthron effectively reduces intracellular lipid contents and enhances glucose consumption in vitro via activation of AMPK signaling pathway. 10 μM Danthron/24 h is safe for HepG2 cells. With 80% confluence, HepG2 cells are incubated with Danthron (0.1-10 μM) in FBS-Free media for 8 h. Subsequently, cells are harvested for Western blot assay. Danthron increases the p-AMPK protein in a dose-dependent manner, and no changes in t-AMPK protein are observed. Danthron inhibits 9-cis retinoic acid (9cRA)-induced retinoic X receptor α (RXRα) transactivation by IC 50 at 0.11 μM. To further clarify the stoichimetric ratio of Danthron binding to RXRα-ligand-binding domain (LBD), isothermal titration calorimetry (ITC) experiment is performed. The K D value of Danthron binds to RXRα-LBD by ITC experiment is determined at 7.5 μM.
Danthron functions as an insulin sensitizer in vivo. Danthron improves insulin sensitivity in diet-induced obese (DIO) mice. The insulin tolerance test result shows that Danthron (5 mg/kg) treated diet-induced obesity mice exhibit lower glucose levels after insulin challenge, compared with the control vehicle-treated group.